Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tag: access to drug data

4 11/17/2016

The secret reasons why statins may not be as useful as we think

1 3/10/2016

Xarelto controversy highlights need for more transparency at NEJM

9/12/2013

Petition: drug safety data are not trade secrets